[go: up one dir, main page]

DE60303101D1 - Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen - Google Patents

Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Info

Publication number
DE60303101D1
DE60303101D1 DE60303101T DE60303101T DE60303101D1 DE 60303101 D1 DE60303101 D1 DE 60303101D1 DE 60303101 T DE60303101 T DE 60303101T DE 60303101 T DE60303101 T DE 60303101T DE 60303101 D1 DE60303101 D1 DE 60303101D1
Authority
DE
Germany
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60303101T
Other languages
English (en)
Other versions
DE60303101T2 (de
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of DE60303101D1 publication Critical patent/DE60303101D1/de
Application granted granted Critical
Publication of DE60303101T2 publication Critical patent/DE60303101T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60303101T 2003-06-30 2003-06-30 Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen Expired - Lifetime DE60303101T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291601A EP1367061B1 (de) 2003-06-30 2003-06-30 Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Publications (2)

Publication Number Publication Date
DE60303101D1 true DE60303101D1 (de) 2006-03-30
DE60303101T2 DE60303101T2 (de) 2006-09-28

Family

ID=29414888

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60303101T Expired - Lifetime DE60303101T2 (de) 2003-06-30 2003-06-30 Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Country Status (17)

Country Link
US (1) US7179833B2 (de)
EP (1) EP1367061B1 (de)
JP (1) JP4347341B2 (de)
CN (1) CN1802384B (de)
AR (1) AR044944A1 (de)
AT (1) ATE315043T1 (de)
AU (1) AU2004253721B2 (de)
DE (1) DE60303101T2 (de)
DK (1) DK1367061T3 (de)
EA (1) EA008836B1 (de)
ES (1) ES2256689T3 (de)
MY (1) MY139159A (de)
NZ (1) NZ544003A (de)
PL (1) PL211161B1 (de)
SI (1) SI1367061T1 (de)
WO (1) WO2005003153A1 (de)
ZA (1) ZA200510330B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286393T3 (es) * 2003-06-30 2007-12-01 Les Laboratoires Servier Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
EP1380591B1 (de) * 2003-08-29 2005-11-16 Les Laboratoires Servier Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
US7615571B2 (en) * 2004-05-31 2009-11-10 Ipca Laboratories Ltd. Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt
JP5133061B2 (ja) * 2004-10-20 2013-01-30 エシコン・インコーポレイテッド 強化された吸収性複層の止血用創傷手当て用品および製造方法
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
EP1679072B9 (de) 2005-01-06 2009-09-02 IPCA Laboratories Limited Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
US7291745B2 (en) 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
RU2433998C1 (ru) * 2010-03-16 2011-11-20 Закрытое акционерное общество "Активный Компонент" Способ получения периндоприла и его фармацевтически приемлемых солей
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
SI9500140A (en) * 1995-04-24 1996-10-31 Genesis Para La Investigacion Novel n-sulfoxy anhydrides, process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
ES2240919T3 (es) * 2003-03-12 2005-10-16 Les Laboratoires Servier Nuevo procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables.
US20050171165A1 (en) * 2003-11-12 2005-08-04 Bhirud Shekhar B. Process for the preparation of perindopril

Also Published As

Publication number Publication date
EP1367061B1 (de) 2006-01-04
CN1802384B (zh) 2010-06-16
WO2005003153A1 (fr) 2005-01-13
PL211161B1 (pl) 2012-04-30
JP2007537974A (ja) 2007-12-27
EA008836B1 (ru) 2007-08-31
AU2004253721B2 (en) 2007-12-20
AU2004253721A1 (en) 2005-01-13
ZA200510330B (en) 2007-05-30
US20060178421A1 (en) 2006-08-10
ATE315043T1 (de) 2006-02-15
EA200501925A1 (ru) 2006-06-30
DK1367061T3 (da) 2006-05-15
SI1367061T1 (sl) 2006-04-30
NZ544003A (en) 2009-03-31
ES2256689T3 (es) 2006-07-16
PL380408A1 (pl) 2007-01-22
DE60303101T2 (de) 2006-09-28
EP1367061A1 (de) 2003-12-03
MY139159A (en) 2009-08-28
US7179833B2 (en) 2007-02-20
JP4347341B2 (ja) 2009-10-21
AR044944A1 (es) 2005-10-12
CN1802384A (zh) 2006-07-12
HK1089188A1 (en) 2006-11-24

Similar Documents

Publication Publication Date Title
DE60129800D1 (de) Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
EP1513403A4 (de) Herzglykoside für die behandlung von mukoviszidose und anderen il-8-bedingten erkrankungen
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
EP1730113A4 (de) Verfahren zur synthese eines cxcr4-antagonisten
DE60303101D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60311942D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60313391D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch geeigneten Salze
FR2868414B1 (fr) Procede de production d'alpha-alumine particulaire et apha-alumine particulaire produite par ce procede
ATE365714T1 (de) Verfahren zur herstellung von hochreinem perindopril und zwischenverbindungen nützlich in der synthese
DE60301820D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60300581D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60308102D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen i2003/26ö
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
DE60319196D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60302287D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60301930D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salze
DE60307925D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60307721D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60311730D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60336931D1 (de) Verfahren zur synthese der bisbenzimidazolen und ihren derivaten.
ATE534624T1 (de) Verfahren und zwischenprodukte für die herstellung von n-(1-benzhydryl-azetidin-3-yl)-n- phenyl-methylsulphonamid-derivaten
ATE344800T1 (de) Substituierte [1,4öbenzodioxin[2,3-eöisoindol- derivaten, ihr verfahren zur herstellung und ihre pharmazeutische zusammensetzungen
FR2861727B1 (fr) Procede de synthese directe d'alkylhalogenosilanes
DE602005020131D1 (de) Syntheseverfahren und zwischenprodukte zur herstellung von rizatriptan

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition